Hugo Arasanz: specialist in Medical Oncology, specialized in thoracic oncology and central nervous system tumors, and Doctor of Health Sciences from the Public University of Navarra (2020). He actively participates in clinical trials, some of them as principal investigator, and was coordinator of the FER-FEN-2019-01 trial. In recent years he has participated in different basic/translational research projects with competitive funding, two of them as principal investigator, focused on cancer immunotherapy, biomarker studies, as well as treatment resistance and molecular pathways. He has more than 50 publications in indexed journals, with an h-index of 21.
World's Top 2% Scientists (Stanford University)
Dr. David Escors Murugarren is a Spanish researcher born in Pamplona, Navarre, in 1974. He earned a degree in Biological Sciences from the University of Navarre and completed his doctoral thesis at the Autonomous University of Madrid in 2002. His thesis focused on the structure of the coronavirus of transmissible porcine gastroenteritis and the encapsidation of its genome. After completing his doctorate, he continued his postdoctoral training as a Marie Curie researcher at University College London (UCL), where he collaborated on research about lentiviral vectors and their use in cancer immunotherapy. In 2013, he returned to Spain and joined the Navarrabiomed Research Center, where he leads the immunomodulation group. Dr. Escors specializes in oncological immunotherapy and has published more than one hundred articles, reviews, and book chapters. His research focuses on the development of new immunotherapies for solid tumors, and he has been awarded the V SER Navarra Award (Innovation Category) for his work in research on the
SARS-CoV-22.
(me dice copilot que a ver si no es : SARS-CoV-2)
Eduardo Albéniz holds a medical degree (Medicine and Surgery) from the University of Navarra (1998) and specialized in Digestive System (MIR) at Ramón y Cajal Hospital in Madrid (1999-2003). Professionally, he has worked at HU Angers-France (2003), Hospital San Rafael in Madrid (2003-2004), and Complejo Hospitalario Universitario de Albacete (2004-2009). Since 2009, he has worked as a Consultant Gastroenterologist in the Endoscopy Unit of the Digestive System Service at the University Hospital of Navarra (HUN). Furthermore, since 2018 he combines his clinical activity with research thanks to several fellowships for Intensification (50% research activity; 50% clinical activity). These fellowships enabled him to complete his PhD in Medicine at the Public University of Navarra in 2021.
Dr. Albéniz has coordinated since 2013 the national Endoscopic Resection group of the Spanish Society of Digestive Endoscopy (SEED), whose main work is to promote national and international collaborative research in this field.
Since 2023, he has been a Member of the Board of Directors and Chair of the society´s scientific Committee. In addition, he coordinates the research activity of the Digestive System Service, the Resection and treatment unit for digestive motor disorders, and the CSUR functional unit for achalasia of the HUN.
Throughout his career, he has been a tutor for residents and, currently, he is directing 3 doctoral theses. He has participated in 38 research projects, 22 of them as PI and 10 of them awarded with competitive funding (SEED, ESGE, SVNPD, MEDTECH Navarra and ISCIII). He has also collaborated in the development of the European ESGE (European Society of Gastrointestinal Endoscopy) guidelines on Endoscopic Mucosal Resection and on training in POEM (Per-Oral Endoscopy Miotomy). As a result of this work, Dr. Albéniz is the author of more than 90 scientific publications in journals with a high impact index.